Login / Signup
Jameel Muzaffar
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Binding Protein
Vascular Endothelial Growth Factor
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Glenn J Hanna
,
Myung-Ju Ahn
,
Jameel Muzaffar
,
Bhumsuk Keam
,
Daniel W Bowles
,
Deborah J Wong
,
Alan L Ho
,
Sung-Bae Kim
,
Francis P Worden
,
Tak Yun
,
Xianzhang Meng
,
Jan M Van Tornout
,
Maureen G Conlan
,
Hyunseok Kang
A Phase 2 Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)